v3.22.2.2
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2022
Dec. 31, 2021
Current Assets    
Cash and cash equivalents $ 16,416,069 $ 20,581,313
Accounts receivable 5,492 12,510
Prepaid expenses 825,748 598,367
Other current assets 426,228 786,642
Total Current Assets 17,673,537 21,978,832
Property and equipment, net 4,880,663 4,911,077
Operating lease right-of-use assets 657,557 383,551
Intangible assets, net 129,600 216,876
Total Assets 23,341,357 27,490,336
Current Liabilities    
Accounts payable 2,467,672 1,542,457
Accrued liabilities 3,069,288 3,828,501
Deferred revenue 10,000,000 12,512
Management and directors' fees payable 71,642 71,303
Current portion of long-term debt 1,064,741 797,855
Current portion of finance lease liabilities 41,693 48,958
Current portion of operating lease liabilities 232,161 171,166
Current portion of grant repayable 30,908 43,100
Total Current Liabilities 16,978,105 6,515,852
Long-term debt, net of current portion 2,275,045 2,270,767
Finance lease liabilities, net of current portion 408,344 511,086
Operating lease liabilities, net of current portion 449,326 217,305
Grant repayable, net of current portion 390,709 253,221
Total Liabilities 20,501,529 9,768,231
Stockholders' Equity    
Common Stock Authorized: 100,000,000 shares of common stock, at $0.001 par value Issued and outstanding: 57,496,003 shares and 53,772,261 shares, respectively 57,496 53,772
Additional paid-in capital 162,939,998 154,730,938
Accumulated other comprehensive income 315,546 148,326
Accumulated deficit (160,015,333) (136,988,636)
Total VolitionRx Limited Stockholders' Equity 3,297,707 17,944,400
Non-controlling interest (457,879) (222,295)
Total Stockholders' Equity 2,839,828 17,722,105
Total Liabilities and Stockholders' Equity $ 23,341,357 $ 27,490,336

Source